{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T19:07:31Z","timestamp":1792868851141,"version":"4.5.0"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To explore the implementation of cardiovascular risk management (CVRM) in Dutch RA patients from the perspective of rheumatologists and patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online survey was conducted among Dutch rheumatologists, rheumatology physician assistants (PAs) and RA patients. Healthcare providers completed a 37-item adapted version of the Determinants of Implementation Behavior Questionnaire to assess various aspects of CVRM implementation behaviour on a 7-point Likert scale. Simultaneously, a 13-item questionnaire was administered to RA patients to gather experiences related to CVRM. Data for both surveys were collected online between 23 September and 1 December 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 85 healthcare providers [93% rheumatologists, mean age 47.2\u2009years (s.d. 8.8), 72% female] and 145 RA patients [mean age 58\u2009years (s.d. 12.6), 89% female] completed the survey. Providers did not seem to lack (self-reported) knowledge on CVRM, yet significant implementation challenges were identified across several domains, including skills, professional roles and beliefs about capabilities. Time constraints, limited resources, insufficient financial support and the absence of local protocols were cited as major barriers. From the patient perspective, only 39% reported being informed about RA-related cardiovascular risks, mostly by rheumatologists. Rheumatologists frequently provided guidance on physical activity (21%), while general practitioners were more active in managing traditional cardiovascular risk factors, prescribing medications (23%) and offering self-management advice (16%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study highlights the main challenges in implementing CVRM in daily practice, indicating the need for the development of targeted strategies to overcome these barriers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkag015","type":"journal-article","created":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T10:15:44Z","timestamp":1769422544000},"source":"Crossref","is-referenced-by-count":1,"title":["Exploring cardiovascular risk management implementation in Dutch rheumatoid arthritis patients: insights from rheumatologists and patients"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1327-5973","authenticated-orcid":false,"given":"Mariia","family":"Oliinyk","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Sint Maartenskliniek , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4783-8663","authenticated-orcid":false,"given":"Johanna E","family":"Vriezekolk","sequence":"additional","affiliation":[{"name":"Department of Research, Sint Maartenskliniek , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9362-9451","authenticated-orcid":false,"given":"Henk","family":"Schers","sequence":"additional","affiliation":[{"name":"Department of Primary Care Medicine, Radboudumc , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd","family":"Heslinga","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, St Jansdal Hospital , Harderwijk,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8543-1237","authenticated-orcid":false,"given":"Karen","family":"Bevers","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Sint Maartenskliniek , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-9896","authenticated-orcid":false,"given":"Caroline","family":"van Durme","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Maastricht UMC+ , Maastricht,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6274-1934","authenticated-orcid":false,"given":"Michael T","family":"Nurmohamed","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Reade , Amsterdam,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1432-069X","authenticated-orcid":false,"given":"Sander I","family":"van Leuven","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Radboudumc , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9470-9720","authenticated-orcid":false,"given":"Calin D","family":"Popa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Sint Maartenskliniek , Nijmegen,","place":["The Netherlands"]},{"name":"Department of Rheumatology, Radboudumc , Nijmegen,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"key":"2026021306011870600_rkag015-B1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/S0140-6736(22)01349-6","article-title":"Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK","volume":"400","author":"Conrad","year":"2022","journal-title":"Lancet"},{"key":"2026021306011870600_rkag015-B2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/rheumatology\/kem202","article-title":"Systemic inflammation as a risk factor for atherothrombosis","volume":"47","author":"van Leuven","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"2026021306011870600_rkag015-B3","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1002\/art.40892","article-title":"A multicenter, randomized, placebo-controlled trial of atorvastatin for the primary prevention of cardiovascular events in patients with rheumatoid arthritis","volume":"71","author":"Kitas","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026021306011870600_rkag015-B4","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1136\/annrheumdis-2016-210997","article-title":"Low disease activity (DAS28\u22643.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study","volume":"76","author":"Arts","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026021306011870600_rkag015-B5","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2026021306011870600_rkag015-B6","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026021306011870600_rkag015-B7","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJMoa1809798","article-title":"Low-dose methotrexate for the prevention of atherosclerotic events","volume":"380","author":"Ridker","year":"2019","journal-title":"N Engl J Med"},{"key":"2026021306011870600_rkag015-B8","doi-asserted-by":"publisher","first-page":"152132","DOI":"10.1016\/j.semarthrit.2022.152132","article-title":"In RA patients without prevalent CVD, incident CVD is mainly associated with traditional risk factors: a 20-year follow-up in the CARR\u00c9 cohort study","volume":"58","author":"Raadsen","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2026021306011870600_rkag015-B9","doi-asserted-by":"publisher","first-page":"e003485","DOI":"10.1136\/rmdopen-2023-003485","article-title":"Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated","volume":"9","author":"Raadsen","year":"2023","journal-title":"RMD Open"},{"key":"2026021306011870600_rkag015-B10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1136\/ard.2009.113696","article-title":"EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis","volume":"69","author":"Peters","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2026021306011870600_rkag015-B11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","article-title":"EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update","volume":"76","author":"Agca","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026021306011870600_rkag015-B12","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1136\/heartjnl-2016-310111","article-title":"Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care","volume":"102","author":"Emanuel","year":"2016","journal-title":"Heart"},{"key":"2026021306011870600_rkag015-B13","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/acr.21935","article-title":"Challenges of cardiovascular risk assessment in the routine rheumatology outpatient setting: an observational study of 110 rheumatoid arthritis patients","volume":"65","author":"Gossec","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026021306011870600_rkag015-B14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/acr.22966","article-title":"Implementing an electronic medical record\u2013based reminder for cardiovascular risk screening in rheumatoid arthritis","volume":"69","author":"Akenroye","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026021306011870600_rkag015-B15","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/msc.1196","article-title":"Cardiovascular risk management in rheumatoid arthritis: a large gap to close","volume":"16","author":"Ladak","year":"2018","journal-title":"Musculoskeletal Care"},{"key":"2026021306011870600_rkag015-B16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ijcard.2016.08.129","article-title":"Exploring cardiovascular disease risk evaluation in patients with inflammatory joint diseases","volume":"223","author":"Semb","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026021306011870600_rkag015-B17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s41927-020-0112-5","article-title":"Views of primary care physicians and rheumatologists regarding screening and treatment of hyperlipidemia among patients with rheumatoid arthritis","volume":"4","author":"Navarro-Mill\u00e1n","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2026021306011870600_rkag015-B18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s41927-020-00123-w","article-title":"Barriers and facilitators for screening and treatment of hyperlipidemia among patients with inflammatory arthritis","volume":"4","author":"Navarro-Mill\u00e1n","year":"2020","journal-title":"BMC Rheumatol"},{"key":"2026021306011870600_rkag015-B19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/03009742.2019.1600718","article-title":"Suboptimal cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk screening programme","volume":"48","author":"Heslinga","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"2026021306011870600_rkag015-B20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s00296-020-04533-4","article-title":"Strategies for implementation of guideline recommended cardiovascular risk management for patients with rheumatoid arthritis: results from a questionnaire survey of expert rheumatology centers","volume":"40","author":"Weijers","year":"2020","journal-title":"Rheumatol Int"},{"key":"2026021306011870600_rkag015-B21","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1093\/rheumatology\/kew039","article-title":"Marked underdiagnosis and undertreatment of hypertension and hypercholesterolaemia in rheumatoid arthritis","volume":"55","author":"van Breukelen-van der Stoep","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"2026021306011870600_rkag015-B22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1136\/annrheumdis-2017-eular.3188","article-title":"SAT0114 Poor cardiovascular risk management in rheumatoid arthritis patients despite an explicit cardiovascular risk management program","volume":"76","author":"Heslinga","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2026021306011870600_rkag015-B23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.ijcard.2018.06.111","article-title":"Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases","volume":"274","author":"Ikdahl","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026021306011870600_rkag015-B24","doi-asserted-by":"publisher","first-page":"e001724","DOI":"10.1136\/rmdopen-2021-001724","article-title":"Diabetes mellitus and cardiovascular risk management in patients with rheumatoid arthritis: an international audit","volume":"7","author":"Semb","year":"2021","journal-title":"RMD Open"},{"key":"2026021306011870600_rkag015-B25","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.2196\/jmir.6.3.e34","article-title":"Improving the quality of web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES)","volume":"6","author":"Eysenbach","year":"2004","journal-title":"J Med Internet Res"},{"key":"2026021306011870600_rkag015-B26","author":"Castor","year":"2019"},{"key":"2026021306011870600_rkag015-B27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1748-5908-9-33","article-title":"Measuring determinants of implementation behavior: psychometric properties of a questionnaire based on the theoretical domains framework","volume":"9","author":"Huijg","year":"2014","journal-title":"Implement Sci"},{"key":"2026021306011870600_rkag015-B28","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1002\/acr.21976","article-title":"Patient-reported quality of care for osteoarthritis: development and testing of the osteoarthritis quality indicator questionnaire","volume":"65","author":"\u00d8ster\u00e5s","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026021306011870600_rkag015-B29","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1186\/s12913-022-08014-1","article-title":"Quality of knee osteoarthritis care in the Netherlands: a survey on the perspective of people with osteoarthritis","volume":"22","author":"Oomen","year":"2022","journal-title":"BMC Health Serv Res"},{"key":"2026021306011870600_rkag015-B30","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1136\/annrheumdis-2017-212392","article-title":"Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care","volume":"77","author":"Weijers","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"2026021306011870600_rkag015-B31","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/rheumatology\/kew497","article-title":"Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the implementation of cardiovascular risk management in rheumatoid arthritis project","volume":"56","author":"van den Oever","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026021306011870600_rkag015-B32","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1093\/rheumatology\/kex054","article-title":"Cardiovascular risk management in rheumatoid arthritis: challenges ahead","volume":"56","author":"Popa","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026021306011870600_rkag015-B33","author":"Nederlandse Vereniging voor Reumatologie","year":"2026"},{"key":"2026021306011870600_rkag015-B34","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/acr.25026","article-title":"Influence of smoking on disease activity and quality of life in patients with rheumatoid arthritis: results from a Swedish case\u2013control study with longitudinal follow-up","volume":"75","author":"Alfredsson","year":"2023","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026021306011870600_rkag015-B35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.berh.2016.10.006","article-title":"Cardiovascular disease in inflammatory rheumatic diseases","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"2026021306011870600_rkag015-B36","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1136\/annrheumdis-2019-eular.7766","article-title":"AB0294 the effect of smoking on endothelin-1 in patients with rheumatoid arthritis","volume":"78","author":"Cienfuegos","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026021306011870600_rkag015-B37","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.autrev.2016.01.010","article-title":"Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy","volume":"15","author":"Iannone","year":"2016","journal-title":"Autoimmun Rev"},{"key":"2026021306011870600_rkag015-B38","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1136\/annrheumdis-2013-205094","article-title":"Overweight decreases the chance of achieving good response and low disease activity in early rheumatoid arthritis","volume":"73","author":"Sandberg","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"2026021306011870600_rkag015-B39","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3389\/fimmu.2014.00576","article-title":"Obesity as a risk and severity factor in rheumatic diseases (autoimmune chronic inflammatory diseases)","volume":"5","author":"Gremese","year":"2014","journal-title":"Front Immunol"},{"key":"2026021306011870600_rkag015-B40","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/acr.21768","article-title":"Obesity and reduction of the response rate to anti\u2013tumor necrosis factor \u03b1 in rheumatoid arthritis: an approach to a personalized medicine","volume":"65","author":"Gremese","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026021306011870600_rkag015-B41","doi-asserted-by":"publisher","first-page":"10420","DOI":"10.1038\/s41598-019-46927-w","article-title":"Overweight\/obesity affects histological features and inflammatory gene signature of synovial membrane of rheumatoid arthritis","volume":"9","author":"Alivernini","year":"2019","journal-title":"Sci Rep"},{"key":"2026021306011870600_rkag015-B42","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41584-021-00593-3","article-title":"Cardiovascular effects of approved drugs for rheumatoid arthritis","volume":"17","author":"Atzeni","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"2026021306011870600_rkag015-B43","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Coxib and traditional NSAID Trialists\u2019 Collaboration","year":"2013","journal-title":"Lancet"},{"key":"2026021306011870600_rkag015-B44","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2109927","article-title":"Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis","volume":"386","author":"Ytterberg","year":"2022","journal-title":"N Engl J Med"},{"key":"2026021306011870600_rkag015-B45","doi-asserted-by":"publisher","first-page":"e001591","DOI":"10.1136\/rmdopen-2021-001591","article-title":"Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial","volume":"7","author":"van Boheemen","year":"2021","journal-title":"RMD Open"},{"key":"2026021306011870600_rkag015-B46","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/S0140-6736(04)16449-0","article-title":"Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial","volume":"363","author":"McCarey","year":"2004","journal-title":"Lancet"},{"key":"2026021306011870600_rkag015-B47","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/art.40889","article-title":"Exploring the lipid paradox theory in rheumatoid arthritis: associations of low circulating low-density lipoprotein concentration with subclinical coronary atherosclerosis","volume":"71","author":"Giles","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026021306011870600_rkag015-B48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1136\/ard.2006.066191","article-title":"Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis","volume":"66","author":"Popa","year":"2007","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkag015\/66636024\/rkag015.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkag015\/66636024\/rkag015.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkag015\/66636024\/rkag015.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:01:24Z","timestamp":1770980484000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkag015\/8444844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkag015","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rkag015"}}